Overexpression of HIF-1α occurs in a wide range of primary and metastatic cancers [5], and is responsible for a range of tumour-related properties including a reduction in reactive oxygen species [6], increased radio-resistance [7]–[9], and protection of cells from drug induced apoptosis [10] and senescence [11]. Here, HIF1A is linked to neoplasm.